MedPath

Hair loss restraint by scalp cooling enforcement

Phase 2
Suspended
Conditions
Breast cancer
Registration Number
JPRN-jRCTs072180051
Lead Sponsor
TOKUNAGA Eriko
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Suspended
Sex
Female
Target Recruitment
21
Inclusion Criteria

1)Histologically comfirmed primary breast cancer
2)Stage I, II or III
3)Female aged 20 to 75 years old
4)The case for that is planned anthracycline, taxan-based chemotherapy and in that hair loss is expected
5)No history of the chemotherapy for the malignant tumor
6)Signed informed consent of the patient for registration

Exclusion Criteria

1)Chilly allergy
2)Cold agglutinin disease
3)Any scalp skin tumor
4)History of radiation for head
5)Temporomandibular disorder or disease to a chin
6)Any other cases who are regarded as inadequate for study enrollment by the attending doctors

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Rate of grade 0 or 1 of hair loss, according to CTCAE ver4.0 classification
Secondary Outcome Measures
NameTimeMethod
Rate of hair loss restraint in each evaluation timing <br>Hair loss accompanying symptom <br>Hair loss period <br>Safety <br>Adverse events
© Copyright 2025. All Rights Reserved by MedPath